|SEQ_NO||1||Date of announcement||2021/05/13||Time of announcement||17:26:28|
|Subject||Announcement of TTY Biopharm's unaudited income information in April 2021|
|Date of events||2021/05/13||To which item it meets||paragraph 53|
|Statement||1.Date of occurrence of the event:2021/05/13
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $353,723 thousands(expressed in NT dollars; unaudited), a consolidated operating profit of $88,509 thousands, and a consolidated income before tax of $89,709 thousands in April 2021; net income attributed to stockholders of the company was $70,503 thousands; EPS is $0.28.
Year-to-date consolidated net sales was $1,317,779 thousands (in NT dollars; unaudited), a consolidated operating profit was $307,671 thousands and consolidated income before tax was $342,753 thousands until April 2021; year-to-date net income attributed to stockholders of the company was $273,646 thousands; EPS is $1.10.
7.Any other matters that need to be specified:The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.